Initiating retinopathy of prematurity screening in a tertiary care hospital in a resource-constrained setting: challenges and outcomes
Initiating screening of retinopathy of prematurity in neonates
DOI:
https://doi.org/10.52442/jrmi.v11i3.958Keywords:
Birth Weight, Gestational Age, Retinopathy of Prematurity, ScreeningAbstract
Introduction: Retinopathy of prematurity (ROP) affects preterm infants with less than 2000 grams and a gestational age of 35 weeks or less, who are treated in the Neonatal Intensive Care Unit (NICU). The sequelae of ROP can be prevented by a meticulous screening program, which is the need of the day in Low- and Middle-Income Countries (LMICs) like Pakistan.
Objectives: To evaluate the burden of ROP and the challenges encountered during the screening of ROP in a tertiary care hospital of Peshawar, Pakistan.
Materials and Methods: This cross-sectional study was conducted in the MTI Lady Reading Hospital, Peshawar Pakistan, between May 2022 and June 2024. All the preterm infants (n=501) born before the gestational age (GA) of 35 weeks and/or with birth weight of less than 2000 grams, and who were exposed to uncontrolled Oxygen in NICU care, were included. Dilated fundoscopy was done to determine the presence or absence and the stage of ROP by a pediatric ophthalmologist. The screening results and the difficulties encountered during the initiation of the program were assessed.
Results: Out of 501 enrolled preterm infants 349 (≈ 70%) babies expired before undergoing screening. Among the remaining 152 neonates who were screened, ROP was detected in 16.4%. Additionally, 17.2% of the screened infants required follow-up and observation, while 8.3% were referred for further treatment. The primary challenges faced were poverty (45.5%), poor parental compliance (15.3%) and inadequate coordination by the healthcare coordinator (15.3%).
Conclusion: The initiation of ROP screening in a resource-constrained hospital has multifactorial challenges with its success dependent on the commitment of all stakeholders.
References
Sabri K, Ells AL, Lee EY, Dutta S, Vinekar A. Retinopathy of prematurity: a global perspective and recent developments. Pediatr. 2022 Aug 1;150(3). Doi: 10.1542/peds.2021-053924.
Vinekar A, Dogra M, Azad R, Gilbert C, Gopal L, Trese M. The changing scenario of retinopathy of prematurity in middle- and low-income countries: Unique solutions for unique problems. Indian J Ophthalmol. 2019;67(6):717. Doi: 10.4103/ijo.IJO_496_19.
Chawanpaiboon S, Vogel JP, Moller AB, Lumbiganon P, Petzold M, Hogan D, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health [Internet]. 2019 Jan 1;7(1): e37–46. Doi: 10.1016/S2214-109X(18)30451-0.
Schmidt B, Whyte RK. Oxygen saturation target ranges and alarm settings in the NICU: what have we learnt from the neonatal oxygenation prospective meta-analysis (NeOProM)? In: Seminars in Fetal and Neonatal Medicine. Elsevier; 2020. p. 101080.
Welsford M, Nishiyama C, Shortt C, Weiner G, Roehr CC, Isayama T, et al. Initial oxygen use for preterm newborn resuscitation: a systematic review with meta-analysis. Pediatr. 2019;143(1). Doi: 10.1542/peds.2018-1828.
Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63(5):618–37. Doi: 10.1016/j.survophthal.2018.04.002.
Adams GGW. ROP in Asia. Eye [Lond]. 2020;34(4):607–8. Doi: 10.1038/s41433-019-0620-y.
Cestari YL, Lima MA, Rezende ML, Fonseca LM. Risk factors for retinopathy of prematurity: a systematic review. Rev Bras Oftalmol. 2021 Nov 22;80(6): e0052. Doi: 10.37039/1982.8551.20210052
Fierson WM, Chiang MF, Good W, Phelps D, Reynolds J, Robbins SL, et al. Screening examination of premature infants for retinopathy of prematurity. Pediatr. 2018;142(6). Doi: 10.1542/peds.2018-306.
Sadiq MAA, Karamat I, Khan AA. Retinopathy of prematurity in Pakistan. JAAPOS. 2016;20(6):541–2. Doi: 10.1016/j.jaapos.2016.09.016.
Moin M, Mian LS, Gilbert C, Irfan A, Mian UK. Blindness in infants presenting with advanced and untreated ROP: a single-centre study in Pakistan. BMJ Open Ophthalmol. 2022;7(1): e000911. Doi: 10.1136/bmjophth-2021-000911.
Chaudhry TA, Hashmi FK, Salat MS, Khan QA, Ahad A, Taqui AM, et al. Retinopathy of prematurity: an evaluation of existing screening criteria in Pakistan. British J Ophthalmol. 2014;98(3):298–301. Doi: 10.1136/bjophthalmol-2013-304018.
Moin M, Azam A, Mian LS, Pal A, Kareem R, Us Sehar N. Improving ROP management: insights from a comparative analysis of screening and treatment modalities in a tertiary hospital, Pakistan. BMC Ophthalmol. 2025;25(1):1–7. Doi: 10.1186/s12886-025-03865-8.
Rajan RP, Kohli P, Babu N, Dakshayini C, Tandon M, Ramasamy K. Treatment of retinopathy of prematurity (ROP) outside International Classification of ROP (ICROP) guidelines. Graefes Arch Clin Exp Ophthalmol. 2020 Jun; 258: 1205-10. Doi: 10.1007/s00417-020-04706-8.
Awan MA, Haq A, Shaheen F, Nazir S, Choudhry S. Frequency and outcome of retinopathy of Prematurity at Tertiary Care Hospital in Pakistan. J Coll Physicians Surg Pak. 2022;32(7):895–8. Doi: 10.29271/jcpsp.2022.07.895.
Saeidi R, Izanloo A, Habibnejad R. P435 Retinopathy of prematurity prevalence and risk factors in developing countries. Arch Dis Child. 2019;104(Suppl 3): A326. Doi: 10.1136/archdischild-2019-epa.771.
Braimah IZ, Enweronu-Laryea C, Sackey AH, Kenu E, Agyabeng K, Ofori-Adjei IODB, et al. Incidence and risk factors of retinopathy of prematurity in Korle-Bu Teaching Hospital: a baseline prospective study. BMJ Open. 2020;10(8): e035341. Doi: 10.1136/bmjopen-2019-035341.
Manley BJ, Kuschel CA, Elder JE, Doyle LW, Davis PG. Higher rates of retinopathy of prematurity after increasing oxygen saturation targets for very preterm infants: experience in a single center. J Pediatr. 2016; 168: 242 -4. Doi: 10.1016/j.jpeds.2015.10.005.
Goldstein GP, Leonard SA, Kan P, Koo EB, Lee HC, Carmichael SL. Prenatal and postnatal inflammation-related risk factors for retinopathy of prematurity. J Perinatol. 2019;39(7):964–73. Doi: 10.1038/s41433-022-02234-9.
Kennedy NU, Ademola-Popoola D. Coverage and Challenges of Retinopathy of Prematurity Screening and Treatment in Nigeria: Perspectives of Ophthalmologists and Paediatricians. Niger J Ophthalmol. 2020;28(2):61–9. Doi: 10.4103/njo.njo_19_20.
Bain LC, Kristensen-Cabrera AI, Lee HC. A qualitative analysis of challenges and successes in retinopathy of prematurity screening. Am J Perinatol. 2018;8(02): e128–33. Doi: 10.1055/s-0038-1660519.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Rehman Medical Institute

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
